AngioLab (XKRX:251280) Other Operating Expense : ₩1,145.7 Mil (TTM As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is AngioLab Other Operating Expense?

AngioLab's Other Operating Expense for the six months ended in Dec. 2023 was ₩1,145.7 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₩1,145.7 Mil.

AngioLab's quarterly Other Operating Expense declined from Dec. 2021 (₩1,084.3 Mil) to Dec. 2022 (₩1,059.2 Mil) but then increased from Dec. 2022 (₩1,059.2 Mil) to Dec. 2023 (₩1,145.7 Mil).

AngioLab's annual Other Operating Expense declined from Dec. 2021 (₩1,084.3 Mil) to Dec. 2022 (₩1,059.2 Mil) but then increased from Dec. 2022 (₩1,059.2 Mil) to Dec. 2023 (₩1,145.7 Mil).

AngioLab Other Operating Expense Historical Data

The historical data trend for AngioLab's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab Other Operating Expense Chart

AngioLab Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

1,040.42

1,129.86

1,084.30

1,059.22

1,145.73

AngioLab Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Other Operating Expense	Get a 7-Day Free Trial			1,040.42	1,129.86	1,084.30	1,059.22	1,145.73

AngioLab Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₩1,145.7 Mil.

AngioLab Other Operating Expense Related Terms

Thank you for viewing the detailed overview of AngioLab's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

AngioLab (XKRX:251280) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN

Website

http://www.angiolab.co.kr

AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab (XKRX:251280) Headlines

No Headlines